news
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
16 June 2011 | By Novartis
The US FDA has accepted for review its supplemental Biologics License Application...
List view / Grid view
Novartis
news
Horizon successfully completes pilot human gene-editing program
14 June 2011 | By Zyme Communications Ltd
Horizon Discovery has announced that it has successfully completed an eighteen month pilot program with Novartis...
news
Novartis candidate vaccine Bexsero® shows potential against meningococcal serogroup B infections
10 June 2011 | By Novartis
New data from a pivotal study in more than 1,800 infants...
news
Novartis gains European Commission approval for Lucentis®
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
news
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
news
Novartis gains FDA approval for Afinitor®
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
news
Novartis drug Afinitor® recommended by FDA oncology advisory committee
12 April 2011 | By Novartis
Novartis announced that the FDA Oncologic Drugs Advisory Committee recommended approval of Afinitor® (everolimus) tablets...
news
Social media and the pharma industry
11 April 2011 | By GDS International
Every other industry is getting on the social media bandwagon. But could social media actually prove beneficial to the world of pharma?...
news
Novartis shareholders approve merger of Alcon into Novartis
8 April 2011 | By Novartis
Novartis shareholders followed the Board of Directors' recommendation, approving the proposed merger of Alcon, Inc. into Novartis...
news
Novartis first-in-class antiviral DEB025 achieved sustained viral response
31 March 2011 | By Novartis
Novartis announced that a Phase II study with the first-in-class antiviral DEB025 met its primary endpoint for achieving viral cure...
news
Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China
22 March 2011 | By Novartis
Novartis announced that it completed the transaction to acquire an 85 percent stake in Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd...
news
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
news
Novartis appoints Naomi Kelman as new Head of the Novartis OTC division
17 February 2011 | By Novartis
Novartis announced that effective March 2, Naomi Kelman is appointed Head of the Novartis OTC Division...
news
Novartis studies show Onbrez® Breezhaler® & tiotropium provided greater increase in lung function than tiotropium alone
10 February 2011 | By Novartis
Patients with COPD treated with Onbrez® Breezhaler® & tiotropium notice improvements...
news
Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET
9 February 2011 | By Novartis
NEJM published a study that shows Afinitor® tablets plus BSC more than doubled PFS...
